Dexamethasone in brain tumor patients: a real-world pharmacovigilance audit.

Front Neurol · 2025 · PMC12406498 · PMID 40909003

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

showed a trendp = 0.08so close (0.05 < p ≤ 0.1)

Similarly, lack of an MDT steroid plan was significantly linked to Grade 3 complications ( p = 0.01) and showed a trend for Grade 2 ( p = 0.08) but was not associated with Grade 1 toxicity ( p = 0.56).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.